What is he best known for?
The fields of study he is best known for:
Internal medicine, Endocrinology, Substantia nigra, Dopamine and Dopaminergic are his primary areas of study.
His works in Parkinson's disease, Basal ganglia, Dopamine receptor and Dopamine receptor D1 are all subjects of inquiry into Internal medicine.
His Substantia nigra research includes elements of Striatum and Paraquat.
His Striatum study integrates concerns from other disciplines, such as Huntington's disease and Putamen.
His specific area of interest is Dopamine, where Eric K. Richfield studies Tyrosine hydroxylase.
His Tyrosine hydroxylase research integrates issues from Dopamine transporter, Alpha-synuclein, MPTP, Neurochemical and Pharmacology.
His most cited work include:
- Neuronal localization of cannabinoid receptors in the basal ganglia of the rat (477 citations)
- The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. (403 citations)
- Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system. (354 citations)
What are the main themes of his work throughout his whole career to date?
Eric K. Richfield spends much of his time researching Internal medicine, Endocrinology, Dopamine, Neuroscience and Substantia nigra.
His Internal medicine study often links to related topics such as Genetically modified mouse.
All of his Dopamine and Dopaminergic, Dopamine receptor, Tyrosine hydroxylase and Dopamine transporter investigations are sub-components of the entire Dopamine study.
In his study, Cytoarchitecture, C57BL/6, Cerebellar vermis and Cerebellar dysplasia is inextricably linked to Heterotopia, which falls within the broad field of Neuroscience.
His Pars compacta and Nigrostriatal pathway study in the realm of Substantia nigra interacts with subjects such as Maneb.
His studies in Striatum integrate themes in fields like Nucleus accumbens and Huntington's disease.
He most often published in these fields:
- Internal medicine (42.50%)
- Endocrinology (42.50%)
- Dopamine (36.25%)
What were the highlights of his more recent work (between 2008-2017)?
- Neuroscience (23.75%)
- Tyrosine hydroxylase (11.25%)
- Internal medicine (42.50%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Neuroscience, Tyrosine hydroxylase, Internal medicine, Endocrinology and Heterotopia.
His study looks at the relationship between Neuroscience and topics such as Pathology, which overlap with Putamen and Neurochemical.
His Tyrosine hydroxylase research incorporates elements of Ventral tegmental area and Transgene.
His Internal medicine study combines topics in areas such as Pediatrics and Surgical pathology.
His work carried out in the field of Endocrinology brings together such families of science as Autoimmune disease and Headaches.
He frequently studies issues relating to Paraquat and Dopamine.
Between 2008 and 2017, his most popular works were:
- Toxicokinetics and toxicodynamics of paraquat accumulation in mouse brain (71 citations)
- Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice (36 citations)
- Critical Role of Truncated α-Synuclein and Aggregates in Parkinson's Disease and Incidental Lewy Body Disease (32 citations)
In his most recent research, the most cited papers focused on:
Eric K. Richfield mainly investigates Tyrosine hydroxylase, Dopamine, Internal medicine, Endocrinology and Oxidative stress.
His research integrates issues of Genetically modified mouse, Transgene, Neurotransmitter, Parkinsonism and Pars compacta in his study of Tyrosine hydroxylase.
Eric K. Richfield undertakes multidisciplinary investigations into Dopamine and Homovanillic acid in his work.
His Oxidative stress research is multidisciplinary, relying on both Catecholamine, Central nervous system, Toxicodynamics, Toxicokinetics and Paraquat.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
